The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Aethlon Medical Inc (NASDAQ: AEMD) was $0.73 for the day, down -45.62% from the previous closing price of $1.35. In other words, the price has decreased by -$45.62 from its previous closing price. On the day, 6.21 million shares were traded. AEMD stock price reached its highest trading level at $0.8 during the session, while it also had its lowest trading level at $0.6892.
Ratios:
Our analysis of AEMD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.48. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.08.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEMD now has a Market Capitalization of 1907713 and an Enterprise Value of -1170861.
Stock Price History:
The Beta on a monthly basis for AEMD is 1.97, which has changed by -0.7392857 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, AEMD has reached a high of $8.44, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -44.66%, while the 200-Day Moving Average is calculated to be -76.36%.
Shares Statistics:
AEMD traded an average of 2.87M shares per day over the past three months and 16433900 shares per day over the past ten days. A total of 2.60M shares are outstanding, with a floating share count of 2.49M. Insiders hold about 4.05% of the company’s shares, while institutions hold 15.44% stake in the company. Shares short for AEMD as of 1755216000 were 121116 with a Short Ratio of 0.04, compared to 1752537600 on 229563. Therefore, it implies a Short% of Shares Outstanding of 121116 and a Short% of Float of 4.7.
Earnings Estimates
Current recommendations for the stock of the company come from 2.0 analysts. The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.25 and low estimates of -$0.72.
Analysts are recommending an EPS of between -$1.45 and -$3.05 for the fiscal current year, implying an average EPS of -$2.25. EPS for the following year is -$0.57, with 1.0 analysts recommending between -$0.57 and -$0.57.
